Sign In
Free Newsletter
Englewood Health appoints Shin as chief of medicine
Dr. Peter Shin, who has served as section chief of hospital medicine since 2015, succeeds Dr. Alexandra Gottdiener, who was named to the role in 2009.
Atlantic Health adds chief clinical officer (updated)
Dr. Suja Mathew will focus on three key areas: optimizing patient access to the system's full network of care, elevating research and academic programs, and continuing AHS's commitment to high-quality care.
EPA announces $221M loan for NJ water infrastructure
The funding will go toward 28 projects to modernize systems for nearly 6 million state residents.
Soligenix vaccine patent application advances
"Having a vaccine platform such as this available has the potential to accelerate worldwide vaccination campaigns addressing future health emergencies, including other global pandemics as seen with COVID-19,” said research collaborator Axel Lehrer, an associate professor at the University of Hawaiʽi at Mānoa.
NJBIZ Conversations: Dean Paranicas
The president and CEO of the Health Care Institute of New Jersey talks about where growth in the life sciences industry will come from in the near future, government moves to reign in health care costs and the business climate in the state.
Rutgers researchers to provide antibody testing in children’s ‘long COVID’ study
RECOVER is a $470 million National Institutes of Health initiative to understand the frequency and development of the condition, in which people have prolonged symptoms or develop new or returning symptoms after the initial phase of infection. The university's work, called CLOCK, looks at the effect on kids.
Former governor, execs to lead opioid webinar
The panel will discuss how – and why – the crisis is affecting certain populations. It is presented by the Partnership for a Drug-Free New Jersey and the Office of the New Jersey Coordinator of Addiction Responses and Enforcement Strategies.
Milestone expands availability of epidural device
According to the Roseland-based company, the computer-controlled injection was designed to reduce the number of unintentional dural punctures.
Hengrui Pharma launches Princeton-based biotech company
Because it will have access to the clinical studies and facilities of its parent company — one of the largest pharmaceutical firms in China — Luzsana Biotechnology will be able to lower development costs in the hopes of offering affordable drugs to more people globally.
Meet the winners from BioNJ’s 12th Annual BioPartnering Conference
More than 50 startups gave virtual presentations during the event in the hopes of attracting potential investors and partners, with winners announced across Devices & Diagnostics, Digital Medicine/Health IT/AI/Medtech, Research & Development, Start-Up Pitch Presentations and Therapeutics.
Paterson partnership aims to curtail opioid overdoses
The city enlisted software provider Quickbase for a dispatch system that, in short, gets a life-saving prescription to those who need it, and quickly.
RWJUH unveils first phase of surgical services expansion in New Brunswick
The $165 million project broke ground in July 2020. It created five new operating rooms — one a hybrid OR — and features the state's only intraoperative MRI.
